Global and Japan In Vivo Toxicology Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global In Vivo Toxicology Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Chronic Toxicity Testing
  • 1.2.3 Sub-Chronic Toxicity Testing
  • 1.2.4 Sub-Acute Toxicity Testing
  • 1.2.5 Acute Toxicity Testing
• 1.3 Market by Application
  • 1.3.1 Global In Vivo Toxicology Market Share by Application: 2020 VS 2026
  • 1.3.2 Immunotoxicity
  • 1.3.3 Systemic Toxicity
  • 1.3.4 Carcinogenicity
  • 1.3.5 Genotoxicity
  • 1.3.6 Developmental and Reproductive Toxicity (DART)
  • 1.3.7 Other Toxicity Endpoints
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global In Vivo Toxicology Market Perspective (2015-2026)
• 2.2 Global In Vivo Toxicology Growth Trends by Regions
  • 2.2.1 In Vivo Toxicology Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 In Vivo Toxicology Historic Market Share by Regions (2015-2020)
  • 2.2.3 In Vivo Toxicology Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top In Vivo Toxicology Players by Market Size
  • 3.1.1 Global Top In Vivo Toxicology Players by Revenue (2015-2020)
  • 3.1.2 Global In Vivo Toxicology Revenue Market Share by Players (2015-2020)
• 3.2 Global In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by In Vivo Toxicology Revenue
• 3.4 Global In Vivo Toxicology Market Concentration Ratio
  • 3.4.1 Global In Vivo Toxicology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by In Vivo Toxicology Revenue in 2019
• 3.5 Key Players In Vivo Toxicology Area Served
• 3.6 Key Players In Vivo Toxicology Product Solution and Service
• 3.7 Date of Enter into In Vivo Toxicology Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 In Vivo Toxicology Breakdown Data by Type (2015-2026)

• 4.1 Global In Vivo Toxicology Historic Market Size by Type (2015-2020)
• 4.2 Global In Vivo Toxicology Forecasted Market Size by Type (2021-2026)

5 In Vivo Toxicology Breakdown Data by Application (2015-2026)

• 5.1 Global In Vivo Toxicology Historic Market Size by Application (2015-2020)
• 5.2 Global In Vivo Toxicology Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America In Vivo Toxicology Market Size (2015-2026)
• 6.2 North America In Vivo Toxicology Market Size by Type (2015-2020)
• 6.3 North America In Vivo Toxicology Market Size by Application (2015-2020)
• 6.4 North America In Vivo Toxicology Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe In Vivo Toxicology Market Size (2015-2026)
• 7.2 Europe In Vivo Toxicology Market Size by Type (2015-2020)
• 7.3 Europe In Vivo Toxicology Market Size by Application (2015-2020)
• 7.4 Europe In Vivo Toxicology Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China In Vivo Toxicology Market Size (2015-2026)
• 8.2 China In Vivo Toxicology Market Size by Type (2015-2020)
• 8.3 China In Vivo Toxicology Market Size by Application (2015-2020)
• 8.4 China In Vivo Toxicology Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan In Vivo Toxicology Market Size (2015-2026)
• 9.2 Japan In Vivo Toxicology Market Size by Type (2015-2020)
• 9.3 Japan In Vivo Toxicology Market Size by Application (2015-2020)
• 9.4 Japan In Vivo Toxicology Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia In Vivo Toxicology Market Size (2015-2026)
• 10.2 Southeast Asia In Vivo Toxicology Market Size by Type (2015-2020)
• 10.3 Southeast Asia In Vivo Toxicology Market Size by Application (2015-2020)
• 10.4 Southeast Asia In Vivo Toxicology Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific In Vivo Toxicology Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2015-2020))
  • 11.1.5 Thermo Fisher Scientific Recent Development
• 11.2 Danaher
  • 11.2.1 Danaher Company Details
  • 11.2.2 Danaher Business Overview
  • 11.2.3 Danaher In Vivo Toxicology Introduction
  • 11.2.4 Danaher Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.2.5 Danaher Recent Development
• 11.3 Charles River Laboratories
  • 11.3.1 Charles River Laboratories Company Details
  • 11.3.2 Charles River Laboratories Business Overview
  • 11.3.3 Charles River Laboratories In Vivo Toxicology Introduction
  • 11.3.4 Charles River Laboratories Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.3.5 Charles River Laboratories Recent Development
• 11.4 Labcorp
  • 11.4.1 Labcorp Company Details
  • 11.4.2 Labcorp Business Overview
  • 11.4.3 Labcorp In Vivo Toxicology Introduction
  • 11.4.4 Labcorp Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.4.5 Labcorp Recent Development
• 11.5 The Jackson Laboratory
  • 11.5.1 The Jackson Laboratory Company Details
  • 11.5.2 The Jackson Laboratory Business Overview
  • 11.5.3 The Jackson Laboratory In Vivo Toxicology Introduction
  • 11.5.4 The Jackson Laboratory Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.5.5 The Jackson Laboratory Recent Development
• 11.6 Data Sciences International
  • 11.6.1 Data Sciences International Company Details
  • 11.6.2 Data Sciences International Business Overview
  • 11.6.3 Data Sciences International In Vivo Toxicology Introduction
  • 11.6.4 Data Sciences International Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.6.5 Data Sciences International Recent Development
• 11.7 Envigo
  • 11.7.1 Envigo Company Details
  • 11.7.2 Envigo Business Overview
  • 11.7.3 Envigo In Vivo Toxicology Introduction
  • 11.7.4 Envigo Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.7.5 Envigo Recent Development
• 11.8 Eurofins Scientific
  • 11.8.1 Eurofins Scientific Company Details
  • 11.8.2 Eurofins Scientific Business Overview
  • 11.8.3 Eurofins Scientific In Vivo Toxicology Introduction
  • 11.8.4 Eurofins Scientific Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.8.5 Eurofins Scientific Recent Development
• 11.9 Perkinelmer
  • 11.9.1 Perkinelmer Company Details
  • 11.9.2 Perkinelmer Business Overview
  • 11.9.3 Perkinelmer In Vivo Toxicology Introduction
  • 11.9.4 Perkinelmer Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.9.5 Perkinelmer Recent Development
• 11.10 SRI International
  • 11.10.1 SRI International Company Details
  • 11.10.2 SRI International Business Overview
  • 11.10.3 SRI International In Vivo Toxicology Introduction
  • 11.10.4 SRI International Revenue in In Vivo Toxicology Business (2015-2020)
  • 11.10.5 SRI International Recent Development
• 11.11 Taconic Biosciences
  • 10.11.1 Taconic Biosciences Company Details
  • 10.11.2 Taconic Biosciences Business Overview
  • 10.11.3 Taconic Biosciences In Vivo Toxicology Introduction
  • 10.11.4 Taconic Biosciences Revenue in In Vivo Toxicology Business (2015-2020)
  • 10.11.5 Taconic Biosciences Recent Development
• 11.12 Wuxi Apptec
  • 10.12.1 Wuxi Apptec Company Details
  • 10.12.2 Wuxi Apptec Business Overview
  • 10.12.3 Wuxi Apptec In Vivo Toxicology Introduction
  • 10.12.4 Wuxi Apptec Revenue in In Vivo Toxicology Business (2015-2020)
  • 10.12.5 Wuxi Apptec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer